{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2323, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019dd923-622c-750b-8b9c-eca830d9ccdf", "docSlug": "75db9143b9c8", "documentTitle": "Pershing Square portfolio (multi-target)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart highlights a significant performance gap between the fund and the index.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-eca830d9ccdf/6", "deckHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "c8b7eded-df25-4aef-82d3-c82000a7bb48", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Charts and tables showing portfolio performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-eca830d9ccdf", "docSlug": "75db9143b9c8", "documentTitle": "Pershing Square portfolio (multi-target)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 8, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide displays two side-by-side tables categorizing investments as 'Winners' or 'Losers' with their respective percentage returns.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-eca830d9ccdf/8", "deckHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 6, "beatId": "c8b7eded-df25-4aef-82d3-c82000a7bb48", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Charts and tables showing portfolio performance", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-eca830d9ccdf", "docSlug": "75db9143b9c8", "documentTitle": "Pershing Square portfolio (multi-target)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 27, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline-annotated line chart to demonstrate value creation following activist intervention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-eca830d9ccdf/27", "deckHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf#slide-27", "loopMatches": [ { "to": 27, "from": 27, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "f939c42b-11ae-4846-8726-fe94d9cefafa", "evidence": "The use of a before-after chart to show the performance of Allergan stock", "position": 0, "objective": "Highlight the performance of a specific investment", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "a7529341-dd51-4f4e-9bdb-cd237fc4c45b", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Discussion of specific investments and their performance", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-eca830d9ccdf", "docSlug": "75db9143b9c8", "documentTitle": "Pershing Square portfolio (multi-target)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 31, "slideType": "timeline", "function": "summarize", "notes": "The slide uses a line chart with callout boxes to correlate specific news events with stock price drops.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-eca830d9ccdf/31", "deckHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 21, "beatId": "a7529341-dd51-4f4e-9bdb-cd237fc4c45b", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Development", "beatSlug": "development", "evidence": "Discussion of specific investments and their performance", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-eca830d9ccdf", "docSlug": "75db9143b9c8", "documentTitle": "Pershing Square portfolio (multi-target)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 45, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline-annotated line chart to correlate corporate milestones and activist interventions with stock price growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-eca830d9ccdf/45", "deckHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-eca830d9ccdf#slide-45", "loopMatches": [ { "to": 45, "from": 45, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "0135aec8-d7da-40a9-8cd3-46b0f3565237", "evidence": "The use of a before-after chart to show the performance of CP's share price", "position": 1, "objective": "Highlight the performance of another specific investment", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 60, "from": 41, "beatId": "ff642e6a-b006-4baf-9b49-e197b67722dd", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Reflection", "beatSlug": "reflection", "evidence": "Analysis of portfolio performance and lessons learned", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-e9d59a625902", "docSlug": "67f554ef218f", "documentTitle": "Pershing Square portfolio (Allergan, Herbalife, Canadian Pacific, Air Products, Restaurant Brands, Platform Specialty, Zoetis, Howard Hughes, Fannie/Freddie)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 8, "slideType": "comparison_table", "function": "analyze_data", "notes": "The slide uses a split-table format to contrast positive and negative performance contributors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-e9d59a625902/8", "deckHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-e9d59a625902", "docSlug": "67f554ef218f", "documentTitle": "Pershing Square portfolio (Allergan, Herbalife, Canadian Pacific, Air Products, Restaurant Brands, Platform Specialty, Zoetis, Howard Hughes, Fannie/Freddie)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 16, "slideType": "other", "function": "establish_context", "notes": "The diagram uses a central triangle to represent the entity, with inflows from IPO and private phase/rollover sources.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-e9d59a625902/16", "deckHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-e9d59a625902", "docSlug": "67f554ef218f", "documentTitle": "Pershing Square portfolio (Allergan, Herbalife, Canadian Pacific, Air Products, Restaurant Brands, Platform Specialty, Zoetis, Howard Hughes, Fannie/Freddie)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 27, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline-annotated line chart to demonstrate value creation following activist intervention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-e9d59a625902/27", "deckHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-e9d59a625902", "docSlug": "67f554ef218f", "documentTitle": "Pershing Square portfolio (Allergan, Herbalife, Canadian Pacific, Air Products, Restaurant Brands, Platform Specialty, Zoetis, Howard Hughes, Fannie/Freddie)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 30, "slideType": "timeline", "function": "illustrate_case", "notes": "The slide uses callout boxes to annotate specific dates on a line chart, illustrating the correlation between news events and stock price movement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-e9d59a625902/30", "deckHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-e9d59a625902", "docSlug": "67f554ef218f", "documentTitle": "Pershing Square portfolio (Allergan, Herbalife, Canadian Pacific, Air Products, Restaurant Brands, Platform Specialty, Zoetis, Howard Hughes, Fannie/Freddie)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 45, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline-annotated line chart to correlate corporate milestones and activist interventions with stock price growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-e9d59a625902/45", "deckHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-e9d59a625902#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "docSlug": "68effc174d2f", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2017-01-26 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 6, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart highlights the significant outperformance of Pershing Square, L.P. (503.1%) compared to the S&P 500 (163.4%) over the specified period.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fc8b4a7bf3f5/6", "deckHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "docSlug": "68effc174d2f", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2017-01-26 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide explicitly attributes the negative performance to the Valeant investment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fc8b4a7bf3f5/13", "deckHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5#slide-13", "loopMatches": [ { "to": 15, "from": 13, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3ad335db-9ef6-48a5-9540-79f62d3f702a", "evidence": "Slides 13-15 present financial data and progress", "position": 1, "objective": "Show financial data and progress", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.6, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "docSlug": "68effc174d2f", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2017-01-26 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 15, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a table structure to categorize holdings into high-quality businesses (~80%), higher-risk smaller investments (~20%), and a short position (~-9%).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fc8b4a7bf3f5/15", "deckHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5#slide-15", "loopMatches": [ { "to": 15, "from": 13, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "3ad335db-9ef6-48a5-9540-79f62d3f702a", "evidence": "Slides 13-15 present financial data and progress", "position": 1, "objective": "Show financial data and progress", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.6, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "docSlug": "68effc174d2f", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2017-01-26 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 20, "slideType": "before_after", "function": "quantify_opportunity", "notes": "The chart uses a 'before-after' framing to highlight the gap between current targets and potential optimized performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fc8b4a7bf3f5/20", "deckHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5#slide-20", "loopMatches": [ { "to": 86, "from": 20, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "15dacd38-8c07-47d7-bf1b-d6478831b2b3", "evidence": "Slides 20 and 86 show before-and-after results of investment strategy", "position": 0, "objective": "Show impact of investment strategy", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 21, "from": 20, "beatId": "5ebc31d5-ae34-4c86-8c43-ded2b971c7f2", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 20-21 present the problem of low margins", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 20, "from": 20, "beatId": "6b4f5f4a-fcf3-4463-a9ec-aceb333f1953", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slide 20 implies a solution of optimized margins", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "docSlug": "68effc174d2f", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2017-01-26 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 21, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses a red bar for the subject company (Mondelez) and blue bars for peers to highlight the performance gap.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fc8b4a7bf3f5/21", "deckHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5#slide-21", "loopMatches": [ { "to": 86, "from": 20, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "15dacd38-8c07-47d7-bf1b-d6478831b2b3", "evidence": "Slides 20 and 86 show before-and-after results of investment strategy", "position": 0, "objective": "Show impact of investment strategy", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 21, "from": 20, "beatId": "5ebc31d5-ae34-4c86-8c43-ded2b971c7f2", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "Slides 20-21 present the problem of low margins", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 21, "from": 21, "beatId": "4e160f46-5b80-45f8-af05-132d10e2fa51", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slide 21 compares to best-in-class levels, making the problem worse", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "docSlug": "68effc174d2f", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2017-01-26 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 86, "slideType": "before_after", "function": "illustrate_case", "notes": "The chart uses a timeline-based annotation style to correlate stock performance with specific activist interventions and management changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fc8b4a7bf3f5/86", "deckHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fc8b4a7bf3f5#slide-86", "loopMatches": [ { "to": 86, "from": 20, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "15dacd38-8c07-47d7-bf1b-d6478831b2b3", "evidence": "Slides 20 and 86 show before-and-after results of investment strategy", "position": 0, "objective": "Show impact of investment strategy", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fbd6560ed0fd", "docSlug": "86bc67fc6d06", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2018-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 10, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The chart shows Pershing Square significantly outperforming the S&P 500 over the period, despite a sharp decline after 2015.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fbd6560ed0fd/10", "deckHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd#slide-10", "loopMatches": [ { "to": 18, "from": 10, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4c528bf6-5317-4654-bf6f-18c35a9db6f7", "evidence": "Cumulative net returns and organizational evolution", "position": 0, "objective": "Show the logical progression of investment strategy", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.6, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 10, "from": 1, "beatId": "6076afa0-fe84-41dd-8fe7-f079ee90a5de", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Pershing Square's performance metrics", "position": 0, "confidence": 0.7, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fbd6560ed0fd", "docSlug": "86bc67fc6d06", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2018-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 18, "slideType": "other", "function": "summarize", "notes": "The chart uses a stacked bar for headcount (investment vs other) and two line series for financial performance (AUM and Net Return).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fbd6560ed0fd/18", "deckHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd#slide-18", "loopMatches": [ { "to": 18, "from": 10, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "4c528bf6-5317-4654-bf6f-18c35a9db6f7", "evidence": "Cumulative net returns and organizational evolution", "position": 0, "objective": "Show the logical progression of investment strategy", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.6, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 18, "from": 11, "beatId": "ca5fb58e-d53a-4ead-93fa-2a0d76078f63", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Complication", "beatSlug": "complication", "evidence": "Discussion of organizational evolution and challenges", "position": 1, "confidence": 0.7, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fbd6560ed0fd", "docSlug": "86bc67fc6d06", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2018-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 32, "slideType": "before_after", "function": "analyze_data", "notes": "The chart highlights the correlation between activist events and share price appreciation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fbd6560ed0fd/32", "deckHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 19, "beatId": "74c723c8-d3c3-4509-a5fa-53fb115c4903", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Detailed performance metrics for key investments", "position": 2, "confidence": 0.7, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fbd6560ed0fd", "docSlug": "86bc67fc6d06", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2018-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 40, "slideType": "before_after", "function": "expose_contradiction", "notes": "The slide uses a timeline-annotated line chart to correlate specific corporate events with share price volatility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fbd6560ed0fd/40", "deckHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 40, "from": 19, "beatId": "74c723c8-d3c3-4509-a5fa-53fb115c4903", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Detailed performance metrics for key investments", "position": 2, "confidence": 0.7, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-fbd6560ed0fd", "docSlug": "86bc67fc6d06", "documentTitle": "Pershing Square Holdings Portfolio (multi-position) (PSH)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2018-01-29 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 53, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart uses dual y-axes to correlate discount levels with performance trends.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-fbd6560ed0fd/53", "deckHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-fbd6560ed0fd#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 53, "from": 41, "beatId": "fa125d3d-4fe6-4f3f-a136-a52af024c3c0", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Development", "beatSlug": "development", "evidence": "Additional data and appendix", "position": 3, "confidence": 0.7, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-0fffb58e3a0f", "docSlug": "9b4a362a0151", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": "Jeffrey C. Smith", "documentKindSlug": "shareholder-letter", "documentKindLabel": "Shareholder letter", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-02-28 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 2, "slideType": "peer_gap", "function": "expose_gap", "notes": "The slide uses quantitative underperformance data to justify an activist campaign against a merger.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-0fffb58e3a0f/2", "deckHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f#slide-2", "loopMatches": [ { "to": 9, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9478efc2-9f01-4b02-a15d-2d6af84ca74a", "evidence": "The document highlights the underperformance and questions R&D productivity, implying a cost of inaction", "position": 0, "objective": "to highlight the cost of not improving R&D productivity", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 2, "from": 2, "beatId": "b1777d52-1b65-4d01-8339-b4d49bc93da2", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document starts by highlighting the underperformance of Bristol-Myers Share Price", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-0fffb58e3a0f", "docSlug": "9b4a362a0151", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": "Jeffrey C. Smith", "documentKindSlug": "shareholder-letter", "documentKindLabel": "Shareholder letter", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-02-28 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 7, "slideType": "peer_benchmark", "function": "expose_gap", "notes": "The slide uses a combination of a bar chart for historical revenue concentration and a floating bar chart (range) for analyst revenue estimates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-0fffb58e3a0f/7", "deckHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f#slide-7", "loopMatches": [ { "to": 9, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9478efc2-9f01-4b02-a15d-2d6af84ca74a", "evidence": "The document highlights the underperformance and questions R&D productivity, implying a cost of inaction", "position": 0, "objective": "to highlight the cost of not improving R&D productivity", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "b2d08d86-8e4d-47b4-8dc5-26870b4df100", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document then questions the company's R&D productivity", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-0fffb58e3a0f", "docSlug": "9b4a362a0151", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": "Jeffrey C. Smith", "documentKindSlug": "shareholder-letter", "documentKindLabel": "Shareholder letter", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-02-28 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 8, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a stacked area chart to show revenue projections and pull-quotes to highlight past management over-promising.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-0fffb58e3a0f/8", "deckHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f#slide-8", "loopMatches": [ { "to": 9, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9478efc2-9f01-4b02-a15d-2d6af84ca74a", "evidence": "The document highlights the underperformance and questions R&D productivity, implying a cost of inaction", "position": 0, "objective": "to highlight the cost of not improving R&D productivity", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "b2d08d86-8e4d-47b4-8dc5-26870b4df100", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document then questions the company's R&D productivity", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-0fffb58e3a0f", "docSlug": "9b4a362a0151", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": "Jeffrey C. Smith", "documentKindSlug": "shareholder-letter", "documentKindLabel": "Shareholder letter", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-02-28 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 9, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a combination of a line chart to show financial decline and a timeline to show management's shifting narrative.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-0fffb58e3a0f/9", "deckHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f#slide-9", "loopMatches": [ { "to": 9, "from": 2, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "9478efc2-9f01-4b02-a15d-2d6af84ca74a", "evidence": "The document highlights the underperformance and questions R&D productivity, implying a cost of inaction", "position": 0, "objective": "to highlight the cost of not improving R&D productivity", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 7, "beatId": "b2d08d86-8e4d-47b4-8dc5-26870b4df100", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document then questions the company's R&D productivity", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-0fffb58e3a0f", "docSlug": "9b4a362a0151", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": "Jeffrey C. Smith", "documentKindSlug": "shareholder-letter", "documentKindLabel": "Shareholder letter", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-02-28 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 13, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a 'CEO Quote vs. Reality' structure to highlight management failure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-0fffb58e3a0f/13", "deckHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-0fffb58e3a0f#slide-13", "loopMatches": [ { "to": 13, "from": 13, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "996cc727-a228-47d1-8c7f-e4954377a0d3", "evidence": "The document provides select management commentary on R&D productivity", "position": 1, "objective": "to provide a solution that addresses shareholder concerns", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 13, "beatId": "69150cef-b68a-4ac9-9ada-bbc434fbe962", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document provides a solution to improve R&D productivity", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-1b44c5356381", "docSlug": "40ee9cb99aa1", "documentTitle": "Huntsman Corporation (HUN)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2022-03-02 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/lFsNj2UCk9eMhQ26nxdfCqg84vdvUZ43h1T5IQYR86g/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGVlOWNiOTlhYTEvcDAwMS5qcGc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-1b44c5356381/1", "deckHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/GgaCUHgtA6vZ_FsehZKgSSnXlEVwgurXiZn9bjy3HCs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGVlOWNiOTlhYTEvcDAwMS5wbmc", "thumbSrc": "https://imgproxy.kitesheet.com/vo4s82JmqYD3CVMi17UfnKEHm4nXj3LDQ6rLWuAFWX0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGVlOWNiOTlhYTEvcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/frW26PbNzTp18DlqQM85OpuwacDin6CFA_qSUjsMVgQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80MGVlOWNiOTlhYTEvcDAwMS5wbmc" }, { "docId": "019dd923-622c-750b-8b9d-1b44c5356381", "docSlug": "40ee9cb99aa1", "documentTitle": "Huntsman Corporation (HUN)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2022-03-02 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-1b44c5356381/2", "deckHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-1b44c5356381", "docSlug": "40ee9cb99aa1", "documentTitle": "Huntsman Corporation (HUN)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2022-03-02 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 3, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses strong, accusatory language ('deceive', 'disingenuous', 'mislead', 'fooled') to frame the incumbent management as untrustworthy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-1b44c5356381/3", "deckHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381#slide-3", "loopMatches": [ { "to": 90, "from": 3, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "6400df9c-7000-46ee-ad3c-c2ae51fd8f33", "evidence": "The document builds a case against Huntsman's management and governance.", "position": 0, "objective": "Reveal Huntsman's poor performance and governance", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 27, "from": 3, "beatId": "cff3cf56-5f0b-452a-8ff2-38b50aeac012", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "Multiple slides expose contradictions in Huntsman's claims and performance.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-1b44c5356381", "docSlug": "40ee9cb99aa1", "documentTitle": "Huntsman Corporation (HUN)", "authorId": "03_Starboard_Value", "authorName": "Starboard Value", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2022-03-02 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 4, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a classic 'Claim vs. Reality' structure to frame the target company's narrative as deceptive.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-1b44c5356381/4", "deckHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-1b44c5356381#slide-4", "loopMatches": [ { "to": 90, "from": 3, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "6400df9c-7000-46ee-ad3c-c2ae51fd8f33", "evidence": "The document builds a case against Huntsman's management and governance.", "position": 0, "objective": "Reveal Huntsman's poor performance and governance", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.7, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 27, "from": 3, "beatId": "cff3cf56-5f0b-452a-8ff2-38b50aeac012", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "Multiple slides expose contradictions in Huntsman's claims and performance.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-167a31878e2a", "docSlug": "beab175aaed8", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "The quote is used to contrast the 'String of Pearls' strategy with the current merger strategy.", "imagePath": "https://imgproxy.kitesheet.com/ZX5hs8BAGSPNYMkLcsSb9Gn0Rqon1zUpVa_zJCkwkAo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZWFiMTc1YWFlZDgvcDAwMS5wbmc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-167a31878e2a/1", "deckHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 1, "beatId": "5ed91835-3564-4906-817f-6bf0a3099465", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation starts by highlighting the problems with the acquisition's strategic rationale and valuation.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/ycYEvWS9p8jZNpjNVOpIOv39ZnvvcLPTqEVp8plycUM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZWFiMTc1YWFlZDgvcDAwMS5qcGc", "thumbSrc": "https://imgproxy.kitesheet.com/RKl6JPOysPhJKwKVDPrtbEI9y7X-B_qJrhOtS_WnGu0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZWFiMTc1YWFlZDgvcDAwMS5wbmc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/LFBML2gCcl3_BE5GC6FamBxQDsQATX_YJ6quAXa7g8I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iZWFiMTc1YWFlZDgvcDAwMS5qcGc" }, { "docId": "019dd923-622c-750b-8b9d-167a31878e2a", "docSlug": "beab175aaed8", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 9, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a visual equation (Historical Acquisitions + Internal R&D = Success) vs (Celgene Acquisition = High Risk/Patent Cliff) to frame the contradiction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-167a31878e2a/9", "deckHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "1be2f377-bde5-4e96-aa19-6d36bdad8e4b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation agitates the problems, providing more details on the acquisition's flaws and potential risks.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-167a31878e2a", "docSlug": "beab175aaed8", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 16, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a bar chart to show historical revenue concentration and an area chart to show the projected revenue decline of Celgene's portfolio.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-167a31878e2a/16", "deckHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a#slide-16", "loopMatches": [ { "to": 20, "from": 16, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "abb67227-8079-48f4-b3b7-b9f835a4b354", "evidence": "The presentation provides a detailed breakdown of the acquisition's valuation, highlighting the potential $30 billion price tag for the pipeline.", "position": 1, "objective": "How does the acquisition's valuation break down?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "1be2f377-bde5-4e96-aa19-6d36bdad8e4b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation agitates the problems, providing more details on the acquisition's flaws and potential risks.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-167a31878e2a", "docSlug": "beab175aaed8", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 20, "slideType": "valuation_reveal", "function": "show_valuation_bridge", "notes": "Uses a waterfall-style bridge to reallocate synergies from marketed products to the pipeline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-167a31878e2a/20", "deckHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a#slide-20", "loopMatches": [ { "to": 20, "from": 16, "name": "Mece Breakdown", "slug": "40-mece-breakdown", "bestFor": "Problem structuring, ensuring completeness, strategic analysis", "matchId": "abb67227-8079-48f4-b3b7-b9f835a4b354", "evidence": "The presentation provides a detailed breakdown of the acquisition's valuation, highlighting the potential $30 billion price tag for the pipeline.", "position": 1, "objective": "How does the acquisition's valuation break down?", "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage", "confidence": 0.6, "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "1be2f377-bde5-4e96-aa19-6d36bdad8e4b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation agitates the problems, providing more details on the acquisition's flaws and potential risks.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-167a31878e2a", "docSlug": "beab175aaed8", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 24, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a timeline visualization to highlight the gap between historical performance (3 launches in 15 years) and projected performance (10 launches in 8 years).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-167a31878e2a/24", "deckHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a#slide-24", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "51fbe075-66b5-4a33-8803-f580c7273c18", "evidence": "The presentation highlights the potential costs of inaction, implying that shareholders would be better off if the deal is not completed.", "position": 0, "objective": "What are the costs of not addressing the issues with the acquisition?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "1be2f377-bde5-4e96-aa19-6d36bdad8e4b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation agitates the problems, providing more details on the acquisition's flaws and potential risks.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-167a31878e2a", "docSlug": "beab175aaed8", "documentTitle": "Bristol-Myers Squibb Company (BMY)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2019-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 28, "slideType": "scenario_table", "function": "diagnose_problem", "notes": "The chart uses a scatter/line hybrid to show the relationship between 2028 revenue and NPV, highlighting specific failure points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-167a31878e2a/28", "deckHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-167a31878e2a#slide-28", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "51fbe075-66b5-4a33-8803-f580c7273c18", "evidence": "The presentation highlights the potential costs of inaction, implying that shareholders would be better off if the deal is not completed.", "position": 0, "objective": "What are the costs of not addressing the issues with the acquisition?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 197, "from": 28, "beatId": "ee7d6dd4-78b4-420f-b7ec-5087201f1ac6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation implies that an alternative approach is needed, providing a scenario table that shows the deal would destroy value.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-13726e30e3a1", "docSlug": "93bc5d70116e", "documentTitle": "Darden Restaurants, Inc. (DRI)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-03-31 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 8, "slideType": "key_messages", "function": "diagnose_problem", "notes": "The slide uses strong, emotive language ('wrong spin-off', 'value destructive', 'permanently impaired') to frame the management's proposal as a threat to shareholder value.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-13726e30e3a1/8", "deckHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1#slide-8", "loopMatches": [ { "to": 19, "from": 8, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "df2d3040-7d78-43ad-b942-a37394e69518", "evidence": "The document presents valuation concerns and governance critiques", "position": 1, "objective": "Test the hypothesis that the separation is not in investors' best interests", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "ed897727-6779-46ac-af18-2be3bdeb8755", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document highlights valuation concerns and potential destruction of shareholder value", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-13726e30e3a1", "docSlug": "93bc5d70116e", "documentTitle": "Darden Restaurants, Inc. (DRI)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-03-31 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 12, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "The slide uses a 'break-even' analysis to highlight the risk of multiple compression in a spin-off scenario.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-13726e30e3a1/12", "deckHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1#slide-12", "loopMatches": [ { "to": 19, "from": 8, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "df2d3040-7d78-43ad-b942-a37394e69518", "evidence": "The document presents valuation concerns and governance critiques", "position": 1, "objective": "Test the hypothesis that the separation is not in investors' best interests", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "ed897727-6779-46ac-af18-2be3bdeb8755", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document highlights valuation concerns and potential destruction of shareholder value", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-13726e30e3a1", "docSlug": "93bc5d70116e", "documentTitle": "Darden Restaurants, Inc. (DRI)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-03-31 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 14, "slideType": "valuation_table", "function": "show_valuation_bridge", "notes": "The slide uses a valuation bridge to demonstrate the value leakage of keeping real estate assets within an operating company (OpCo) versus separating them into a REIT structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-13726e30e3a1/14", "deckHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1#slide-14", "loopMatches": [ { "to": 87, "from": 14, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f076922b-174b-48e3-9636-f933eda00dce", "evidence": "The document emphasizes the potential destruction of shareholder value", "position": 0, "objective": "Highlight the potential costs of inaction (i.e., allowing the separation to proceed)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 19, "from": 8, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "df2d3040-7d78-43ad-b942-a37394e69518", "evidence": "The document presents valuation concerns and governance critiques", "position": 1, "objective": "Test the hypothesis that the separation is not in investors' best interests", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 14, "from": 8, "beatId": "ed897727-6779-46ac-af18-2be3bdeb8755", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document highlights valuation concerns and potential destruction of shareholder value", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-13726e30e3a1", "docSlug": "93bc5d70116e", "documentTitle": "Darden Restaurants, Inc. (DRI)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-03-31 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 19, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "Uses a custom 'fully-leased EBITDA' metric to normalize for real estate ownership structures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-13726e30e3a1/19", "deckHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1#slide-19", "loopMatches": [ { "to": 87, "from": 14, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f076922b-174b-48e3-9636-f933eda00dce", "evidence": "The document emphasizes the potential destruction of shareholder value", "position": 0, "objective": "Highlight the potential costs of inaction (i.e., allowing the separation to proceed)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" }, { "to": 19, "from": 8, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "df2d3040-7d78-43ad-b942-a37394e69518", "evidence": "The document presents valuation concerns and governance critiques", "position": 1, "objective": "Test the hypothesis that the separation is not in investors' best interests", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 87, "from": 19, "beatId": "8a080961-ba9c-43e7-a2d4-04d2cdae026a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document critiques management and the board's decision-making process", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-13726e30e3a1", "docSlug": "93bc5d70116e", "documentTitle": "Darden Restaurants, Inc. (DRI)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-03-31 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 87, "slideType": "villain_critique", "function": "name_villain", "notes": "Uses visual evidence to support a critique of corporate overhead (G&A).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-13726e30e3a1/87", "deckHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1#slide-87", "loopMatches": [ { "to": 87, "from": 14, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f076922b-174b-48e3-9636-f933eda00dce", "evidence": "The document emphasizes the potential destruction of shareholder value", "position": 0, "objective": "Highlight the potential costs of inaction (i.e., allowing the separation to proceed)", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 87, "from": 19, "beatId": "8a080961-ba9c-43e7-a2d4-04d2cdae026a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document critiques management and the board's decision-making process", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-13726e30e3a1", "docSlug": "93bc5d70116e", "documentTitle": "Darden Restaurants, Inc. (DRI)", "authorId": "03_Starboard_Value", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2014-03-31 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 107, "slideType": "closing_ask", "function": "closing_ask", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-13726e30e3a1/107", "deckHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-13726e30e3a1#slide-107", "loopMatches": [], "arcBeatMatches": [ { "to": 108, "from": 107, "beatId": "3f067ffa-f492-4a66-9a62-b14a75230a24", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents a clear call to action for investors to reject the separation", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e", "docSlug": "cbceb926ed14", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-05-04 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 3, "slideType": "before_after", "function": "illustrate_case", "notes": "The slide uses a timeline-annotated line chart to correlate M&A activity with stock performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/3", "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-3", "loopMatches": [ { "to": 3, "from": 3, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "836ebaf8-4b48-43cf-89fc-dc4e982e83e0", "evidence": "Clear before-and-after comparison", "position": 0, "objective": "Show the success of Jarden under Martin Franklin's leadership", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 3, "from": 3, "beatId": "6cdc6414-c44e-4d30-9f90-47f287ba1f9c", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Setup", "beatSlug": "setup", "evidence": "Introduction to Jarden's success under Martin Franklin's leadership", "position": 0, "confidence": 0.6, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e", "docSlug": "cbceb926ed14", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-05-04 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 11, "slideType": "thesis_headline", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/11", "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e", "docSlug": "cbceb926ed14", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-05-04 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The chart uses a timeline-based annotation style to correlate corporate events with stock performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/15", "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "b3605b89-778c-4fd6-8a6f-f5d0c145c633", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Data and tables supporting Valeant's platform value and growth", "position": 1, "confidence": 0.6, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e", "docSlug": "cbceb926ed14", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-05-04 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 18, "slideType": "comparison_table", "function": "present_framework", "notes": "Uses a qualitative scoring system (full circle, half circle) to assess Valeant against specific criteria.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/18", "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-18", "loopMatches": [ { "to": 20, "from": 18, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "310702b7-f917-441d-80c9-979fa0b820a8", "evidence": "Comparison table and valuation table", "position": 1, "objective": "Evaluate Valeant's platform value", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "b3605b89-778c-4fd6-8a6f-f5d0c145c633", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Data and tables supporting Valeant's platform value and growth", "position": 1, "confidence": 0.6, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e", "docSlug": "cbceb926ed14", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-05-04 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 20, "slideType": "valuation_table", "function": "quantify_opportunity", "notes": "The slide uses a valuation bridge format to justify the acquisition value creation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/20", "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-20", "loopMatches": [ { "to": 20, "from": 18, "name": "Benchmark Gap", "slug": "39-benchmark-gap", "bestFor": "Performance improvement, competitive analysis, target setting", "matchId": "310702b7-f917-441d-80c9-979fa0b820a8", "evidence": "Comparison table and valuation table", "position": 1, "objective": "Evaluate Valeant's platform value", "structure": "Our Performance -> Industry Average -> Best-in-Class -> The Gap = The Opportunity", "confidence": 0.6, "description": "Compare performance against best-in-class to quantify the opportunity" } ], "arcBeatMatches": [ { "to": 20, "from": 15, "beatId": "b3605b89-778c-4fd6-8a6f-f5d0c145c633", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Data and tables supporting Valeant's platform value and growth", "position": 1, "confidence": 0.6, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f3d2cf79022e", "docSlug": "cbceb926ed14", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-05-04 00:00:00", "orientation": "portrait", "aspectRatio": 0.77272725, "pageNumber": 32, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f3d2cf79022e/32", "deckHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f3d2cf79022e#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 32, "from": 32, "beatId": "449a018c-d20b-44f6-9bd2-129d7fccb9f8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Summary", "beatSlug": null, "evidence": "Executive summary of Valeant's platform strategy", "position": 2, "confidence": 0.6, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f6c472e7615d", "docSlug": "b2c1d9cb58c0", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 7, "slideType": "other", "function": "establish_context", "notes": "Right-hand portion of the chart (Sep-Oct 2015, showing sharp price decline) is grayed out with a 'See next page' label, deferring that period to a follow-up slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/7", "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f6c472e7615d", "docSlug": "b2c1d9cb58c0", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 13, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a list format to build a case for regulatory scrutiny.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/13", "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f6c472e7615d", "docSlug": "b2c1d9cb58c0", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 14, "slideType": "timeline", "function": "expose_contradiction", "notes": "The slide uses color-coding to distinguish between Valeant and Philidor entities, with a focus on the timeline of their business relationship.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/14", "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f6c472e7615d", "docSlug": "b2c1d9cb58c0", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 26, "slideType": "preempt_rebuttal", "function": "preempt_rebuttal", "notes": "This slide is designed to defend Pershing Square against potential accusations of complicity or prior knowledge regarding Valeant's controversial Philidor acquisition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/26", "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f6c472e7615d", "docSlug": "b2c1d9cb58c0", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 31, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/31", "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9c-f6c472e7615d", "docSlug": "b2c1d9cb58c0", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": null, "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 35, "slideType": "cite_precedent", "function": "cite_precedent", "notes": "The slide uses a simple callout box to set up a comparison with a past corporate scandal.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9c-f6c472e7615d/35", "deckHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9c-f6c472e7615d#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-062155500d22", "docSlug": "d915f08d7324", "documentTitle": "Herbalife, Ltd. (HLF)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2012-12-20 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 1, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/zk78zfB8eYZTxvqaQnvUKY0fiNaTtk4GT2jSgbt20ro/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kOTE1ZjA4ZDczMjQvcDAwMS5wbmc", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-062155500d22/1", "deckHref": "/decks/019dd923-622c-750b-8b9d-062155500d22", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-062155500d22#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/iINH1U4szqqwSB82yScuYlK2bnMSw7bttKqRqFJjvBI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kOTE1ZjA4ZDczMjQvcDAwMS5qcGc", "thumbSrc": "https://imgproxy.kitesheet.com/AZ95vS2RvuE7RdZbENHPctUapoXVY9_TNHObOtgtndU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kOTE1ZjA4ZDczMjQvcDAwMS5wbmc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Sn2yneIYWRaF4LfKDJgi7XMLMi6pk7YZihkbP9A1SGc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kOTE1ZjA4ZDczMjQvcDAwMS5qcGc" }, { "docId": "019dd923-622c-750b-8b9d-062155500d22", "docSlug": "d915f08d7324", "documentTitle": "Herbalife, Ltd. (HLF)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2012-12-20 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 6, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "Uses a hub-and-spoke diagram to show the duality of the company's messaging.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-062155500d22/6", "deckHref": "/decks/019dd923-622c-750b-8b9d-062155500d22", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-062155500d22#slide-6", "loopMatches": [ { "to": 11, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "bfffe639-7321-4e64-88c6-e7d371690d63", "evidence": "The deck presents a critique of Herbalife's business model and identifies patterns that suggest a pyramid scheme.", "position": 0, "objective": "Identify patterns in Herbalife's business model", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 332, "from": 6, "beatId": "828a5215-5304-4198-b016-f8134ac265b3", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "The deck exposes contradictions in Herbalife's business model and leadership.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-062155500d22", "docSlug": "d915f08d7324", "documentTitle": "Herbalife, Ltd. (HLF)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2012-12-20 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 11, "slideType": "villain_critique", "function": "name_villain", "notes": "Uses a rhetorical question to cast doubt on the legitimacy of the company's business model.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-062155500d22/11", "deckHref": "/decks/019dd923-622c-750b-8b9d-062155500d22", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-062155500d22#slide-11", "loopMatches": [ { "to": 11, "from": 6, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "bfffe639-7321-4e64-88c6-e7d371690d63", "evidence": "The deck presents a critique of Herbalife's business model and identifies patterns that suggest a pyramid scheme.", "position": 0, "objective": "Identify patterns in Herbalife's business model", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [ { "to": 11, "from": 11, "beatId": "9394195e-7457-4d7d-9e9c-ba5b4838ed5f", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Villain Critique", "beatSlug": null, "evidence": "The deck presents a critical view of Herbalife's business model and leadership.", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 332, "from": 6, "beatId": "828a5215-5304-4198-b016-f8134ac265b3", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "The deck exposes contradictions in Herbalife's business model and leadership.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-062155500d22", "docSlug": "d915f08d7324", "documentTitle": "Herbalife, Ltd. (HLF)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2012-12-20 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 62, "slideType": "cite_precedent", "function": "cite_precedent", "notes": "The slide highlights specific legal citations (S.E.C. v. International Loan Network and In re Koscot Interplanetary, Inc.) to support the thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-062155500d22/62", "deckHref": "/decks/019dd923-622c-750b-8b9d-062155500d22", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-062155500d22#slide-62", "loopMatches": [ { "to": 62, "from": 62, "name": "Precedent", "slug": "09-precedent", "bestFor": "Risk mitigation, strategy validation, building confidence in new approaches", "matchId": "245eb480-e92e-4ec1-9c3b-22e82a222bc3", "evidence": "The deck cites precedents to support its claims about pyramid schemes.", "position": 1, "objective": "Cite precedents to support the critique", "structure": "The Precedent Case -> What Happened -> The Parallel -> Applied Learning", "confidence": 0.7, "description": "Use historical or external examples to validate your approach" } ], "arcBeatMatches": [ { "to": 62, "from": 62, "beatId": "38661cfb-d25c-4966-a47b-72dc9598b95c", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Cite Precedent", "beatSlug": null, "evidence": "The deck cites precedents to support its claims about pyramid schemes.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 332, "from": 6, "beatId": "828a5215-5304-4198-b016-f8134ac265b3", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "The deck exposes contradictions in Herbalife's business model and leadership.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-062155500d22", "docSlug": "d915f08d7324", "documentTitle": "Herbalife, Ltd. (HLF)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2012-12-20 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 332, "slideType": "expose_contradiction", "function": "expose_contradiction", "notes": "The slide uses a dual-axis combo chart to correlate executive selling behavior with stock performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-062155500d22/332", "deckHref": "/decks/019dd923-622c-750b-8b9d-062155500d22", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-062155500d22#slide-332", "loopMatches": [ { "to": 334, "from": 332, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "01160ce7-78e5-4bd4-896e-9cbf04557d89", "evidence": "The deck concludes with a call to action and highlights the cost of inaction.", "position": 2, "objective": "Highlight the cost of inaction", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 332, "from": 6, "beatId": "828a5215-5304-4198-b016-f8134ac265b3", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "The deck exposes contradictions in Herbalife's business model and leadership.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-622c-750b-8b9d-062155500d22", "docSlug": "d915f08d7324", "documentTitle": "Herbalife, Ltd. (HLF)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2012-12-20 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 334, "slideType": "closing_ask", "function": "summarize", "notes": "Uses the famous Brandeis quote to justify the activist intent of the presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-622c-750b-8b9d-062155500d22/334", "deckHref": "/decks/019dd923-622c-750b-8b9d-062155500d22", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9d-062155500d22#slide-334", "loopMatches": [ { "to": 334, "from": 332, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "01160ce7-78e5-4bd4-896e-9cbf04557d89", "evidence": "The deck concludes with a call to action and highlights the cost of inaction.", "position": 2, "objective": "Highlight the cost of inaction", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 334, "from": 334, "beatId": "37bb1cef-8f70-4e63-af46-ccd16c2fa312", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Closing Ask", "beatSlug": null, "evidence": "The deck concludes with a call to action.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }